 | |
| Company type | Public |
|---|---|
| Industry | Consumer products |
| Predecessor | Johnson & Johnson (consumer health division) |
| Founded | February 23, 2022 in Wilmington, Delaware, U.S.[1] |
| Headquarters | , U.S. |
Area served | Worldwide |
Key people |
|
| Products | |
| Revenue |  US$15.44 billion (2023) |
 US$2.512 billion (2023) | |
| US$1.664 billion (2023) | |
| Total assets | US$27.85 billion (2023) |
| Total equity | US$11.21 billion (2023) |
Number of employees | c. 22,000 (2023) |
| Subsidiaries | McNeil Consumer Healthcare |
| Website | kenvue |
| Footnotes / references [2] | |
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson,[3] Kenvue is the proprietor of well-known brands such as Aveeno,[4] Band-Aid,[5] Benadryl, Combantrin, Zyrtec,[6] Johnson's,[7] Listerine,[8] Mylanta, Neutrogena,[4] Trosyd, Calpol, Tylenol,[8] and Visine.
Kenvue is incorporated under the Delaware General Corporation Law[1] and is headquartered in the Skillman section of Montgomery Township, New Jersey, with plans to relocate its global headquarters to Summit, New Jersey.[9] Before the spin-off, Johnson & Johnson's consumer health division was based in Skillman, even as its pharmaceutical division and medical technologies division, as well as the overall company headquarters, were located in nearby New Brunswick, New Jersey.
- ^ a b Cite error: The named reference
sec 2023-04-24was invoked but never defined (see the help page). - ^ "Kenvue Inc. 2023 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. March 1, 2024.
- ^ Chapman, Michelle; Murphy, Tom (November 12, 2021). "Johnson & Johnson to split into two, aim for faster growth". Associated Press. Retrieved May 7, 2023.
- ^ a b Kenvue Inc. (July 24, 2023). "Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement". Business Wire (English).
- ^ "Kenvue Showcases Tylenol Precise Cream, First Launch Since IPO". MMR. 40 (10): 18. September 11, 2023.
- ^ Altman, Michael; Atasu, Atalay; Özkaya, Evren (October 18, 2023). "How Kenvue De-Risked Its Supply Chain". Harvard Business Review Digital Articles: 1–8.
- ^ Kenvue Inc. (April 5, 2023). "Kenvue to Begin Trading on the New York Stock Exchange". Business Wire (English).
- ^ a b Lipschultz, Bailey (June 6, 2023). "Tylenol Maker Kenvue Goes From Sure Bet to Question Mark After Year's Biggest IPO". Bloomberg.com: N.PAG.
- ^ "J&J Spinoff Kenvue Locating HQ in Summit", New Jersey Business Magazine, May 1, 2023. Accessed August 29, 2023. "Kenvue, the multibillion-dollar spinoff of Johnson & Johnson’s consumer health business, has chosen to locate its global headquarters in Summit.... Kenvue's product portfolio includes well known products Tylenol, Neutrogena, Listerine and Band-Aid, and the spinoff marks the largest restructuring in Johnson & Johnson's 135-year history.... Currently located in Skillman, Kenvue will slowly make a transition to the Summit East campus."